SinglePoint
SinglePoint plans to have the products on the site within the week and will provide an update when ordering is live for the products.
The product line will include Sport Relief Topical Cream which was designed for use by professional and amateur athletes. Sport Relief is non-detect THC, meaning there are no traces of THC in the topical, and triple-processed to make it our purest formula yet. With non-detect, you can use this formula no matter what your job or profession. Triple-processed means Sport Relief is miles beyond the competition in the purity of the cannabinoids and terpenes that your body is receiving. Sport Relief has no offensive odor and will not stain clothes. Upon application, it creates a pleasant sensation, with no oily or gritty feel to be found.
TorusMed specializes in cutting-edge technological advances in cultivation which produce world-renowned, completely organic, full-plant extract tinctures and topical creams for medical and home remedies. We are committed to the utmost protection of every phase from seed to oil, providing the highest quality, natural product at a price everyone can afford. With our 7-step purity process, cutting-edge cultivation and extraction, TorusMed sets the standard of Hemp extracts. We are inspired by the plant: keep it pure, and the healing is pure. Our extracts contain no contaminants; they are organic, non-GMO, and of the purest quality: the way the plant is supposed to be. Grown for you.
Gordon LeBlanc, Jr., President of TorusMed states, “I am pleased to announce our distribution deal with SinglePoint. We have seen the success SinglePoint has had through SingleSeed.com and believe that TorusMed will be one of the best sellers. TorusMed products have taken years to develop in partnerships with industry experts and other highly qualified parties so we are confident and believe that our products are one of the best in the market.”
“We are excited to add TorusMeds’ line of CBD products. We have met the team and seen the glowing reviews from TorusMed customers. We believe TorusMed and their suite of products will provide additional revenue for SinglePoint,” commented Wil Ralston, President, Singlepoint, Inc.
TorusMed is currently working with renowned doctors and a University to develop CBD that would potentially be pharmaceutical grade. SinglePoint plans to participate in this development with TorusMed and be a part of a new way of facilitating the safe and repeated growth of specific strains of CBD in a controlled environment.
The two sites, Singleseed.com and DIGSHydro.com, are subsidiaries of SING.
About SinglePoint, Inc.
SinglePoint, Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
Read Next
